The role of astrocytes in amyloid production and Alzheimer's disease. Issue 12 (13th December 2017)

• Record Type: Journal Article
• Authors: Frost, Georgia R.; Li, Yue-Ming
• Is Part Of: Open biology. Volume 7:Issue 12(2017)
• Publication Date: 2017-12-13
• Subjects: Alzheimer's disease -- astrogliosis -- neuroinflammation -- amyloid beta; Biology -- Periodicals; 570
• DOI: 10.1098/rsob.170228
• Languages: English
• ISSNs: 2046-2441

Abstract

Abstract : Abstract : Alzheimer's disease (AD) is marked by the presence of extracellular amyloid beta (Aβ) plaques, intracellular neurofibrillary tangles (NFTs) and gliosis, activated glial cells, in the brain. It is thought that Aβ plaques trigger NFT formation, neuronal cell death, neuroinflammation and gliosis and, ultimately, cognitive impairment. There are increased numbers of reactive astrocytes in AD, which surround amyloid plaques and secrete proinflammatory factors and can phagocytize and break down Aβ. It was thought that neuronal cells were the major source of Aβ. However, mounting evidence suggests that astrocytes may play an additional role in AD by secreting significant quantities of Aβ and contributing to overall amyloid burden in the brain. Astrocytes are the most numerous cell type in the brain, and therefore even minor quantities of amyloid secretion from individual astrocytes could prove to be substantial when taken across the whole brain. Reactive astrocytes have increased levels of the three necessary components for Aβ production: amyloid precursor protein, β-secretase (BACE1) and γ-secretase. The identification of environmental factors, such as neuroinflammation, that promote astrocytic Aβ production, could redefine how we think about developing therapeutics for AD.